Mabel Fernandes Figueiró
Research Subjects
Mabel Fernandes Figueiró has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Liza Yurie Teruya Uchimura
HCOR
6 shared publications - Jeane Roza Quintans
HCOR
5 shared publications - Tatiana Yonekura
HCOR
5 shared publications - Aline Marcadenti
Hcor Research Institute, Hospital do Coracao, Sao Paulo 04004-030, Brazil
3 shared publications - Camila Weschenfelder
Pennington Biomedical Research Center, Baton Rouge, USA; Graduate Program in Health Sciences (Cardiology), Instituto de Cardiologia/Fundação Universitária de Cardiologia do Rio Grande do Sul (IC/FUC), Porto Alegre, Brazil
3 shared publications - Elana Stein
Graduate Program in Health Sciences (Cardiology), Instituto de Cardiologia/Fundação Universitária de Cardiologia do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
3 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 48 (4)
Effectiveness of intraoperative blood recovery in surgical patients at risk of transfusion: A rapid review
- 7 September 2026
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 48 (4)
Open AccessEffectiveness of intraoperative blood recovery in surgical patients at risk of transfusion: A rapid review
- Open Access
- 14 August 2026
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 24 (1)
Ongoing improvement of participatory health technology assessment in Brazil’s SUS: 10 lessons from Conitec’s (2012–2025) policy implementation evolution (case) study
- 14 August 2026
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 24 (1)
Open AccessOngoing improvement of participatory health technology assessment in Brazil’s SUS: 10 lessons from Conitec’s (2012–2025) policy implementation evolution (case) study
- Open Access
- 19 February 2026
- Published by Sociedade Brasileira de Medicina de Familia e Comunidade (SBMFC) in Revista Brasileira de Medicina de Família e Comunidade
- Vol. 21 (48) , 1-13
Revisão de escopo sobre mediadores interculturais na atenção primária à saúde: aprimorando o cuidado culturalmente sensível para comunidades migrantes, refugiadas e solicitantes de asilo
Introdução: A atuação de mediadores interculturais configura-se como uma estratégia promissora para a ampliação do acesso a cuidados de saúde culturalmente sensíveis por populações migrantes, refugiadas e solicitantes de asilo. Objetivo: Identificar o papel desempenhado por esses mediadores na atenção primária à saúde, com ênfase em sua contribuição para a redução de barreiras ao cuidado e a promoção da inclusão social e sanitária. Métodos: Trata-se de uma revisão de escopo conduzida conforme as diretrizes metodológicas do Joanna Briggs Institute Reviewer’s Manual e da Preferred Reporting Items for Systematic Reviews and Meta-Analyses — Extension for Scoping Reviews (PRISMAScR). A busca bibliográfica foi realizada em oito bases de dados acadêmicas, complementada por pesquisa no Google Scholar. Foram incluídos estudos publicados em inglês, francês, português e espanhol, sem restrição de data, que abordassem o papel de mediadores interculturais na facilitação do acesso à atenção primária à saúde por populações migrantes, refugiadas e solicitantes de asilo. Resultados: Quatro estudos qualitativos atenderam aos critérios de inclusão, explorando as experiências e práticas desses profissionais em diferentes contextos de sistemas de saúde. Os resultados evidenciam que os mediadores interculturais desempenham um conjunto diversificado de funções voltadas à superação de barreiras linguísticas, culturais e institucionais entre usuários, profissionais de saúde e o sistema de saúde. Entre suas principais atividades destacam-se a interpretação, a tradução cultural, a mediação de conflitos, o fortalecimento de vínculos de confiança e o apoio à navegação pelos serviços de saúde. Conclusões: Os achados sugerem que a incorporação desses profissionais na atenção primária à saúde representa uma estratégia promissora para a promoção de cuidados equitativos, acessíveis e culturalmente apropriados, sobretudo para populações em situação de maior vulnerabilidade.
- 19 February 2026
- Published by Sociedade Brasileira de Medicina de Familia e Comunidade (SBMFC) in Revista Brasileira de Medicina de Família e Comunidade
- Vol. 21 (48) , 1-13
Open AccessRevisão de escopo sobre mediadores interculturais na atenção primária à saúde: aprimorando o cuidado culturalmente sensível para comunidades migrantes, refugiadas e solicitantes de asilo
Introdução: A atuação de mediadores interculturais configura-se como uma estratégia promissora para a ampliação do acesso a cuidados de saúde culturalmente sensíveis por populações migrantes, refugiadas e solicitantes de asilo. Objetivo: Identificar o papel desempenhado por esses mediadores na atenção primária à saúde, com ênfase em sua contribuição para a redução de barreiras ao cuidado e a promoção da inclusão social e sanitária. Métodos: Trata-se de uma revisão de escopo conduzida conforme as diretrizes metodológicas do Joanna Briggs Institute Reviewer’s Manual e da Preferred Reporting Items for Systematic Reviews and Meta-Analyses — Extension for Scoping Reviews (PRISMAScR). A busca bibliográfica foi realizada em oito bases de dados acadêmicas, complementada por pesquisa no Google Scholar. Foram incluídos estudos publicados em inglês, francês, português e espanhol, sem restrição de data, que abordassem o papel de mediadores interculturais na facilitação do acesso à atenção primária à saúde por populações migrantes, refugiadas e solicitantes de asilo. Resultados: Quatro estudos qualitativos atenderam aos critérios de inclusão, explorando as experiências e práticas desses profissionais em diferentes contextos de sistemas de saúde. Os resultados evidenciam que os mediadores interculturais desempenham um conjunto diversificado de funções voltadas à superação de barreiras linguísticas, culturais e institucionais entre usuários, profissionais de saúde e o sistema de saúde. Entre suas principais atividades destacam-se a interpretação, a tradução cultural, a mediação de conflitos, o fortalecimento de vínculos de confiança e o apoio à navegação pelos serviços de saúde. Conclusões: Os achados sugerem que a incorporação desses profissionais na atenção primária à saúde representa uma estratégia promissora para a promoção de cuidados equitativos, acessíveis e culturalmente apropriados, sobretudo para populações em situação de maior vulnerabilidade.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59
Safety of tuberculosis-preventive treatment in children aged under 5 years: A rapid review
Background: This study aimed to synthesize evidence on the safety of tuberculosis-preventive treatment (TPT) in children aged <5 years, including those with immunocompromising conditions. Methods: A rapid review was conducted using PubMed, Embase, Virtual Health Library, and the Cochrane Library, including systematic reviews and primary studies. Results: Five studies were included, assessing isoniazid-based regimens. Adverse events were mild and reversible, such as transient liver enzyme elevations and peripheral neuropathy. Severe hepatotoxicity was rare and primarily reported in children with Human Immunodeficiency Virus (HIV). Conclusions: TPT appears generally safe in children aged <5 years; however, evidence remains limited for shorter regimens and immunocompromised populations.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 59
Open AccessSafety of tuberculosis-preventive treatment in children aged under 5 years: A rapid review
Background: This study aimed to synthesize evidence on the safety of tuberculosis-preventive treatment (TPT) in children aged <5 years, including those with immunocompromising conditions. Methods: A rapid review was conducted using PubMed, Embase, Virtual Health Library, and the Cochrane Library, including systematic reviews and primary studies. Results: Five studies were included, assessing isoniazid-based regimens. Adverse events were mild and reversible, such as transient liver enzyme elevations and peripheral neuropathy. Severe hepatotoxicity was rare and primarily reported in children with Human Immunodeficiency Virus (HIV). Conclusions: TPT appears generally safe in children aged <5 years; however, evidence remains limited for shorter regimens and immunocompromised populations.
- 10 December 2025
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 84 (11) , 2291-2305
MicroRNAs, Nut Consumption, Cardiovascular Risk Factors, and Coronary Artery Disease: A Narrative Review
Coronary artery disease (CAD) remains the leading cause of death worldwide and has a multifactorial etiology involving genetic, metabolic, and behavioral factors. Hypertension and dyslipidemia contribute significantly to atherosclerosis progression, and these conditions may be influenced by microRNAs (miRNAs), which act as post-transcriptional gene expression regulators. In turn, miRNA expression can be modulated by nutrient-dense dietary patterns or cardioprotective foods, such as nuts. Despite growing interest in miRNAs and cardiovascular disease (CVD) risk, few reviews have specifically addressed the unique role of nuts in modulating miRNA expression, particularly regarding gaps in secondary prevention of CAD. This study summarizes the main miRNAs associated with blood pressure, lipid metabolism, and atherosclerotic disease, as well as the current evidence on how nut consumption influences their expression. Several miRNAs, including miR-1, miR-21, the miR-29 family, miR-30a/b, miR-133, miR-143, miR-145, and miR-221/222, are dysregulated in hypertension and associated with circadian blood pressure patterns, left ventricular hypertrophy, and antihypertensive response. Others, such as miR-122, miR-33a/b, miR-148a, miR-483-5p, and miR-145, are linked to lipid metabolism, plaque instability, and ischemic outcomes. Nut-rich diets, particularly the Mediterranean diet, seem to modulate miRNAs associated with pathways involved in lipid homeostasis, endothelial function, and inflammation. Data from clinical trials conducted in primary CVD prevention setting have shown changes in circulating miRNAs in response to diets rich in nuts. Additional studies with Brazil nuts, pistachios, almonds, and walnuts supplementation also reported modulation of miRNAs involved in lipid homeostasis, inflammation, and insulin resistance, including significant changes in expression of miR-15a, miR-21, miR-328, miR-454-3p, miR-29a-3p, miR-192, miR-330-3p, miR-32-5p, miR-29b-3p, and miR-551a. Nonetheless, it appears no studies have yet evaluated the effect of nut supplementation on miRNAs in secondary prevention of CAD. Although the evidence is promising, more research is needed to clarify the impact of nut consumption on miRNA modulation, particularly in secondary prevention of CVD.
- 10 December 2025
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 84 (11) , 2291-2305
MicroRNAs, Nut Consumption, Cardiovascular Risk Factors, and Coronary Artery Disease: A Narrative Review
Coronary artery disease (CAD) remains the leading cause of death worldwide and has a multifactorial etiology involving genetic, metabolic, and behavioral factors. Hypertension and dyslipidemia contribute significantly to atherosclerosis progression, and these conditions may be influenced by microRNAs (miRNAs), which act as post-transcriptional gene expression regulators. In turn, miRNA expression can be modulated by nutrient-dense dietary patterns or cardioprotective foods, such as nuts. Despite growing interest in miRNAs and cardiovascular disease (CVD) risk, few reviews have specifically addressed the unique role of nuts in modulating miRNA expression, particularly regarding gaps in secondary prevention of CAD. This study summarizes the main miRNAs associated with blood pressure, lipid metabolism, and atherosclerotic disease, as well as the current evidence on how nut consumption influences their expression. Several miRNAs, including miR-1, miR-21, the miR-29 family, miR-30a/b, miR-133, miR-143, miR-145, and miR-221/222, are dysregulated in hypertension and associated with circadian blood pressure patterns, left ventricular hypertrophy, and antihypertensive response. Others, such as miR-122, miR-33a/b, miR-148a, miR-483-5p, and miR-145, are linked to lipid metabolism, plaque instability, and ischemic outcomes. Nut-rich diets, particularly the Mediterranean diet, seem to modulate miRNAs associated with pathways involved in lipid homeostasis, endothelial function, and inflammation. Data from clinical trials conducted in primary CVD prevention setting have shown changes in circulating miRNAs in response to diets rich in nuts. Additional studies with Brazil nuts, pistachios, almonds, and walnuts supplementation also reported modulation of miRNAs involved in lipid homeostasis, inflammation, and insulin resistance, including significant changes in expression of miR-15a, miR-21, miR-328, miR-454-3p, miR-29a-3p, miR-192, miR-330-3p, miR-32-5p, miR-29b-3p, and miR-551a. Nonetheless, it appears no studies have yet evaluated the effect of nut supplementation on miRNAs in secondary prevention of CAD. Although the evidence is promising, more research is needed to clarify the impact of nut consumption on miRNA modulation, particularly in secondary prevention of CVD.
- Open Access
- 25 October 2025
- Published by Colégio Brasileiro de Medicina do Estilo de Vida in Congresso Brasileiro de Medicina do Estilo de Vida
- Vol. 8
Physical activity and dietary interventions to prevent Type 2 Diabetes
Introduction: Type 2 diabetes mellitus (T2DM), one of the most prevalent chronic non-communicable diseases, remains a major global health concern. Lifestyle interventions, particularly healthy dietary patterns and regular physical activity, play a pivotal role in T2DM prevention. Objective: To develop an evidence gap map of the effectiveness of Physical Activity and Dietary Interventions for T2DM Prevention based on the high-quality systematic reviews. Methods: Following a comprehensive database search and duplicate removal [PROSPERO CRD42023422444], systematic reviews were independently screened and assessed by two reviewers. Methodological quality was appraised using AMSTAR-2. Only high-quality systematic reviews with meta-analyses of randomized controlled trials were included. Data extraction was performed using the REDCap system. Interventions were classified as dietary, physical activity, or combined, and outcomes were grouped into clinical, anthropometric, epidemiological, economic, and well-being/quality of life categories. Lastly, a visual evidence matrix was generated. Results: Over 3,500 citations were identified, but only four systematic reviews (published between 2007 and 2020) met the inclusion criteria. On average, each review analyzed eight studies (range: 3–12). The most often assessed outcomes were glycemic profile, body weight, and T2DM incidence, corresponding to the clinical, anthropometric, and epidemiological categories, respectively. Across the evidence matrix, 48 findings were identified: 13 inconclusive, 13 positive, 12 null, 8 not reported, and 3 potentially positive. Combined dietary and physical activity interventions yielded 10 positive or potentially positive effects, particularly for clinical, anthropometric, and epidemiological outcomes. Conclusion: Combined dietary and physical activity interventions demonstrate beneficial effects, most notably on anthropometric indicators, biomarker profiles, and T2DM incidence. These findings reinforce the importance of combined lifestyle interventions for individuals at elevated risk of T2DM.
- 25 October 2025
- Published by Colégio Brasileiro de Medicina do Estilo de Vida in Congresso Brasileiro de Medicina do Estilo de Vida
- Vol. 8
Open AccessPhysical activity and dietary interventions to prevent Type 2 Diabetes
Introduction: Type 2 diabetes mellitus (T2DM), one of the most prevalent chronic non-communicable diseases, remains a major global health concern. Lifestyle interventions, particularly healthy dietary patterns and regular physical activity, play a pivotal role in T2DM prevention. Objective: To develop an evidence gap map of the effectiveness of Physical Activity and Dietary Interventions for T2DM Prevention based on the high-quality systematic reviews. Methods: Following a comprehensive database search and duplicate removal [PROSPERO CRD42023422444], systematic reviews were independently screened and assessed by two reviewers. Methodological quality was appraised using AMSTAR-2. Only high-quality systematic reviews with meta-analyses of randomized controlled trials were included. Data extraction was performed using the REDCap system. Interventions were classified as dietary, physical activity, or combined, and outcomes were grouped into clinical, anthropometric, epidemiological, economic, and well-being/quality of life categories. Lastly, a visual evidence matrix was generated. Results: Over 3,500 citations were identified, but only four systematic reviews (published between 2007 and 2020) met the inclusion criteria. On average, each review analyzed eight studies (range: 3–12). The most often assessed outcomes were glycemic profile, body weight, and T2DM incidence, corresponding to the clinical, anthropometric, and epidemiological categories, respectively. Across the evidence matrix, 48 findings were identified: 13 inconclusive, 13 positive, 12 null, 8 not reported, and 3 potentially positive. Combined dietary and physical activity interventions yielded 10 positive or potentially positive effects, particularly for clinical, anthropometric, and epidemiological outcomes. Conclusion: Combined dietary and physical activity interventions demonstrate beneficial effects, most notably on anthropometric indicators, biomarker profiles, and T2DM incidence. These findings reinforce the importance of combined lifestyle interventions for individuals at elevated risk of T2DM.
- Open Access
- 5 August 2024
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 37
Brazilian Policies and Programs in Urgent and Emergency Care Services in the Context of Cardiovascular Diseases: A Scoping Review
Introduction Cardiovascular diseases (CVD) are a major cause of mortality in Brazil, requiring the improvement of healthcare mechanisms that can promote rapid and effective care for patients. Objectives To identify and characterize Brazilian policies and programs (PP) regarding urgency and emergency care in the context of CVD. Method The scoping review followed recommendations from the Joanna Briggs Institute (JBI). The search for studies was conducted across seven databases. The screening and eligibility steps were performed by reviewers independently, with [...] Abstract Introduction Cardiovascular diseases (CVD) are a major cause of mortality in Brazil, requiring the improvement of healthcare mechanisms that can promote rapid and effective care for patients. Objectives To identify and characterize Brazilian policies and programs (PP) regarding urgency and emergency care in the context of CVD. Method The scoping review followed recommendations from the Joanna Briggs Institute (JBI). The search for studies was conducted across seven databases. The screening and eligibility steps were performed by reviewers independently, with
- 5 August 2024
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 37
Open AccessBrazilian Policies and Programs in Urgent and Emergency Care Services in the Context of Cardiovascular Diseases: A Scoping Review
Introduction Cardiovascular diseases (CVD) are a major cause of mortality in Brazil, requiring the improvement of healthcare mechanisms that can promote rapid and effective care for patients. Objectives To identify and characterize Brazilian policies and programs (PP) regarding urgency and emergency care in the context of CVD. Method The scoping review followed recommendations from the Joanna Briggs Institute (JBI). The search for studies was conducted across seven databases. The screening and eligibility steps were performed by reviewers independently, with [...] Abstract Introduction Cardiovascular diseases (CVD) are a major cause of mortality in Brazil, requiring the improvement of healthcare mechanisms that can promote rapid and effective care for patients. Objectives To identify and characterize Brazilian policies and programs (PP) regarding urgency and emergency care in the context of CVD. Method The scoping review followed recommendations from the Joanna Briggs Institute (JBI). The search for studies was conducted across seven databases. The screening and eligibility steps were performed by reviewers independently, with
- 5 July 2024
- Published by Springer Nature in European Journal of Nutrition
- Vol. 63 (7) , 2391-2405
Effect of nuts on lipid profile and inflammatory biomarkers in atherosclerotic cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials
Purpose Nut-enriched diets are related to improve lipid and inflammatory biomarkers in meta-analyses in the context of primary cardiovascular prevention. However, primary studies on secondary cardiovascular prevention are scarce and controversial. This systematic review and meta-analysis aimed to evaluate the effect of nut supplementation on lipid and inflammatory profiles in individuals with atherosclerotic cardiovascular disease, and the frequency of adverse events. Methods Six databases were used for research: PubMed, EMBASE, BVS, Cochrane Library, Web of Science, and ClinicalTrials.gov, until February 2023, with no language restrictions. We performed random-effects meta-analyses to compare nut-enriched diets vs. control diets for pre-post intervention changes. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system assessed the evidence’s certainty. Results From the 5187 records identified, eight publications containing data referring to five randomized clinical trials involving 439 participants were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with doses ranging between 5 g and 85 g (median: 30 g/day). The intervention time varied between 6 and 12 weeks. Compared to nut-free diets, nut intake did not have a statistically significant effect on lipid profile biomarkers, except on the atherogenic index (MD: -0.32 [95% CI -0.58 to -0.06], I2 = 0% - moderate certainty of the evidence). Similarly, there was no effect of nuts on inflammatory profile biomarkers. It was not possible to aggregate data on adverse events. Conclusions Nut supplementation did not change lipid and inflammatory profiles in the secondary cardiovascular prevention setting.
- 5 July 2024
- Published by Springer Nature in European Journal of Nutrition
- Vol. 63 (7) , 2391-2405
Effect of nuts on lipid profile and inflammatory biomarkers in atherosclerotic cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials
Purpose Nut-enriched diets are related to improve lipid and inflammatory biomarkers in meta-analyses in the context of primary cardiovascular prevention. However, primary studies on secondary cardiovascular prevention are scarce and controversial. This systematic review and meta-analysis aimed to evaluate the effect of nut supplementation on lipid and inflammatory profiles in individuals with atherosclerotic cardiovascular disease, and the frequency of adverse events. Methods Six databases were used for research: PubMed, EMBASE, BVS, Cochrane Library, Web of Science, and ClinicalTrials.gov, until February 2023, with no language restrictions. We performed random-effects meta-analyses to compare nut-enriched diets vs. control diets for pre-post intervention changes. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system assessed the evidence’s certainty. Results From the 5187 records identified, eight publications containing data referring to five randomized clinical trials involving 439 participants were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with doses ranging between 5 g and 85 g (median: 30 g/day). The intervention time varied between 6 and 12 weeks. Compared to nut-free diets, nut intake did not have a statistically significant effect on lipid profile biomarkers, except on the atherogenic index (MD: -0.32 [95% CI -0.58 to -0.06], I2 = 0% - moderate certainty of the evidence). Similarly, there was no effect of nuts on inflammatory profile biomarkers. It was not possible to aggregate data on adverse events. Conclusions Nut supplementation did not change lipid and inflammatory profiles in the secondary cardiovascular prevention setting.
- 23 May 2024
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 83 (2) , e144-e156
Effect of Nuts on Anthropometric and Glycemic Indexes and Blood Pressure in Secondary Cardiovascular Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Nut-enriched diets have a positive impact on cardiovascular risk factors, such as body mass, blood pressure, and fasting blood glucose. However, studies in individuals undergoing secondary cardiovascular prevention show controversial results. This systematic review with meta-analysis assessed the effect of nut supplementation on anthropometric, glycemic, and blood pressure indices in patients with atherosclerotic cardiovascular disease, as well as the frequency of adverse events. Six databases were used for the search—PubMed, Cochrane Library, EMBASE, BVS (Biblioteca Virtual da Saude), Web of Science, and ClinicalTrials.gov—until February 2023, with no language restrictions. The Cochrane Handbook for Systematic Reviews of Interventions methodology and the PICOS (Population, Intervention, Comparison, Outcome, Setting/design) strategy were used. Seven independent reviewers were involved in data extraction and resolution of disagreements. Certainty of the evidence was evaluated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. From 5187 records identified, 6 publications containing data referring to 5 randomized clinical trials (n = 436) were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with portions that varied between 5 g and 85 g (median: 30 g/day). The intervention period varied between 6 and 12 weeks. The nuts had no effect on fasting glucose and anthropometric indices, although the certainty of the evidence for most of these outcomes was low or very low. They also had no effect on systolic (mean difference [MD]: -1.16 mmHg [95% CI, -5.68 to 3.35], I2 = 0%—moderate certainty of evidence) or diastolic (MD: 0.10 mmHg [95% CI, -2.30 to 2.51], I2 = 0%—high certainty of evidence) blood pressure. It was not possible to aggregate data on adverse events. Nut supplementation had no effect on blood pressure, fasting glucose, or anthropometric profile in the context of atherosclerotic cardiovascular disease. PROSPERO registration no. CRD42020163456.
- 23 May 2024
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 83 (2) , e144-e156
Effect of Nuts on Anthropometric and Glycemic Indexes and Blood Pressure in Secondary Cardiovascular Prevention: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Nut-enriched diets have a positive impact on cardiovascular risk factors, such as body mass, blood pressure, and fasting blood glucose. However, studies in individuals undergoing secondary cardiovascular prevention show controversial results. This systematic review with meta-analysis assessed the effect of nut supplementation on anthropometric, glycemic, and blood pressure indices in patients with atherosclerotic cardiovascular disease, as well as the frequency of adverse events. Six databases were used for the search—PubMed, Cochrane Library, EMBASE, BVS (Biblioteca Virtual da Saude), Web of Science, and ClinicalTrials.gov—until February 2023, with no language restrictions. The Cochrane Handbook for Systematic Reviews of Interventions methodology and the PICOS (Population, Intervention, Comparison, Outcome, Setting/design) strategy were used. Seven independent reviewers were involved in data extraction and resolution of disagreements. Certainty of the evidence was evaluated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. From 5187 records identified, 6 publications containing data referring to 5 randomized clinical trials (n = 436) were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with portions that varied between 5 g and 85 g (median: 30 g/day). The intervention period varied between 6 and 12 weeks. The nuts had no effect on fasting glucose and anthropometric indices, although the certainty of the evidence for most of these outcomes was low or very low. They also had no effect on systolic (mean difference [MD]: -1.16 mmHg [95% CI, -5.68 to 3.35], I2 = 0%—moderate certainty of evidence) or diastolic (MD: 0.10 mmHg [95% CI, -2.30 to 2.51], I2 = 0%—high certainty of evidence) blood pressure. It was not possible to aggregate data on adverse events. Nut supplementation had no effect on blood pressure, fasting glucose, or anthropometric profile in the context of atherosclerotic cardiovascular disease. PROSPERO registration no. CRD42020163456.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 33 (spe1) , e2024319
A hormonioterapia e os riscos de câncer em pessoas transgênero: revisão sistemática
Objetivo Identificar as evidências disponíveis sobre o risco de desenvolver câncer em pessoas transgênero que se tratam por meio de hormonioterapia.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Epidemiologia e Serviços de Saúde
- Vol. 33 (spe1) , e2024319
Open AccessA hormonioterapia e os riscos de câncer em pessoas transgênero: revisão sistemática
Objetivo Identificar as evidências disponíveis sobre o risco de desenvolver câncer em pessoas transgênero que se tratam por meio de hormonioterapia.